Investors Overview
Company Profile
Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Crescita owns a portfolio of non-prescription skincare products and has one FDA approved prescription product, Pliaglis that is licensed globally to Galderma SA and Taro Pharmaceuticals for the U.S. market. Crescita owns the sales and marketing rights in Canada and Mexico.
Stock Snapshot
| Symbol | CTX | Price | |
| Market | TSX | Change | |
| Market Cap | Volume | ||
Report of Organizational Actions Affecting Basis of Securities
– March 30, 2016
Crescita Share Valuation
– March 14, 2016
Recent News
Transfer Agent
AST Trust Company (Canada)
P.O. Box 700, Station B
Montreal, QC
Canada H3B 3K3
Telephone: 1-800-387-0825 or outside Canada and U.S. 416-682-3860
Fax: 1-888-249-6189 or outside Canada and U.S. 514-985-8843
Website: www.canstockta.com
Email: inquiries@canstockta.com
Company Contacts
Crescita Therapeutics Inc.
7560 Airport Road, Unit 10
Mississauga, Ontario
Canada L4T 4H4
Telephone: (905) 673-4295
Investor Relations
Email: ir@crescitatx.com
Telephone: (905) 673-4297
2805 Place Louis.-R.-Renaud
Laval, Quebec
H7V 0A3
Telephone: 450-688-7768
Website: www.integaskin.com